col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


66 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Neuroimmunology
  Original Artikel Datum Titel Autoren   Max. 6 Autoren
1 [GO] 2025―Jul―25 SARS-CoV-2 spike antibody and T cell response in MS patients on high efficacy therapies post vaccine Shrishti Saxena, Alena Zhirova, Rajesh Krishnan, Brian Healy, Eunnindy Sanon, Niveditha Gopalakrishnan, Alyssa Solberg, Sarah Conway, Tanuja Chitnis
2 [GO] 2025―Mrz―19 Ofatumumab for the treatment of COVID-19-associated autoimmune encephalitis: A case report Zhuoran Wang, Xiaoping Du, Qiong Wang, Yating Zhang, Junhong Guo, Huifang Wang
3 [GO] 2024―Jun―01 Neurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis Mihyun Hwang, Cornelia C. Bergmann
4 [GO] 2024―Apr―30 Causal association between multiple sclerosis and severe COVID-19: A bidirectional Mendelian randomization study Shuangjie Li, Dongren Sun, Rui Wang, Qin Du, Hongxi Chen, Ziyan Shi, Hongyu Zhou
5 [GO] 2024―Mrz―05 Follow-up of cognitive impairment and inflammatory profile in individuals with mild COVID-19 Nathália Gualberto Souza-Silva, Daniela Valadão Rosa, Jonas Jardim de Paula, Roney Santos Coimbra, Débora Marques Miranda, Marco Aurélio Romano-Silva
6 [GO] 2024―Feb―04 Caveolin-1 mediates blood-brain barrier permeability, neuroinflammation, and cognitive impairment in SARS-CoV-2 infection Troy N. Trevino, Ali A. Almousawi, KaReisha F. Robinson, Avital B. Fogel, Jake Class, Richard D. Minshall, Leon M. Tai, Justin M. Richner, Sarah E. Lutz
7 [GO] 2024―Jan―08 SARS-CoV-2 induces inflammation and intracranial infection through the olfactory epithelium-olfactory bulb pathway in non-human primates Shino Shimizu, Misako Nakayama, Cong Thanh Nguyen, Hirohito Ishigaki, Yoshinori Kitagawa, Fumihiko Yasui, Yoshiki Yagi, Tomoe Kusayanagi, Michinori Kohara, Yasushi Itoh, Ichiro Tojima, Hideaki Kouzaki, Takeshi Shimizu
8 [GO] 2023―Nov―21 Hydroxyurea interaction with α7 nicotinic acetylcholine receptor can underlie its therapeutic efficacy upon COVID-19 Olena Lykhmus, Olena Kalashnyk, Raymond Sullivan, Maryna Skok
9 [GO] 2023―Nov―21 Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection Ying Chen, Wenbin Wan, Xiaoying Yao, Yangtai Guan
10 [GO] 2023―Sep―28 Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis Sonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, Britt Stævnsbo Pedersen, Sebastian Rask Hamm, Laura Pérez-Alós, Cecilie Bo Hansen, Mia Marie Pries-Heje, Line Dam Heftdal, Rasmus Bo Hasselbalch, Kamille Fogh, Johannes Roth Madsen, Ruth Frikke-Schmidt, Linda Maria Hilsted, Erik Sørensen, Sisse Rye Ostrowski, Henning Bundgaard, Peter Garred, Kasper Iversen, Susanne Dam Nielsen, John Vissing
11 [GO] 2023―Aug―29 SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients Tyler L. Borko, Ryan Baxter, Berenice Cabrera-Martinez, Eagappanath Thiruppathi, Maite Sabalza, Iswariya Venkataraman, Sean Selva, Cody Rester, Stefan Sillau, Daniel M. Pastula, Jeffrey L. Bennett, Enrique Alvarez, Robert Gross, Anna Shah, Ryan Kammeyer, John R. Corboy, Ross M. Kedl, Elena W.Y. Hsieh, Amanda L. Piquet
12 [GO] 2023―Jun―17 Ablation of microglia following infection of the central nervous system with a neurotropic murine coronavirus infection leads to increased demyelination and impaired remyelination Yuting Cheng, Dominic Ibarra Javonillo, Collin Pachow, Vanessa M. Scarfone, Kellie Fernandez, Craig M. Walsh, Kim N. Green, Thomas E. Lane
13 [GO] 2022―Dez―23 Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review Francesca Bosello, Damiano Marastoni, Francesca Benedetta Pizzini, Chiara Zaffalon, Andrea Zuliani, Giulia Turri, Sara Mariotto, Erika Bonacci, Emilio Pedrotti, Massimiliano Calabrese
14 [GO] 2022―Nov―28 Brain stem encephalitis is a rare complication of COVID-19 Marc C. Shamier, Yvette S. Crijnen, Susanne Bogers, Jeroen W. IJpelaar, Juna M. de Vries, Mathieu van der Jagt, Jochem K.H. Spoor, Jan H. von der Thüsen, Marco W.J. Schreurs, Corine H. GeurtsvanKessel, Maarten J. Titulaer
15 [GO] 2022―Okt―28 Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review Ehab Harahsheh, Marcus Callister, Shemonti Hasan, David Gritsch, Cristina Valencia-Sanchez
16 [GO] 2022―Okt―17 Encephalitis, myocarditis, and thrombocytopenia after COVID-19 mRNA vaccination: Clinical and pathophysiological considerations Nicholas G. Kounis, Virginia Mplani, Periklis Dousdampanis, Panagiotis Plotas, Ioanna Koniari
17 [GO] 2022―Aug―02 Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review Parissa Feizi, Kanika Sharma, Shreya R. Pasham, Lalit Nirwan, Joe Joseph, Shruti Jaiswal, Shitiz Sriwastava
18 [GO] 2022―Jul―14 Myelin oligodendrocyte glycoprotein-IgG1 associated disorders (MOGAD) following SARS-CoV-2 infection: A case series Jeffrey Lambe, Marisa P. McGinley, Brandon P. Moss, Yang Mao-Draayer, Roman Kassa, John R. Ciotti, Sara Mariotto, Amy Kunchok
19 [GO] 2022―Mai―08 COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report Md Asaduzzaman, Bidrum Purkayastha, M. M. Jahangir Alam, Shishir Ranjan Chakraborty, Soumitra Roy, Nasad Ahmed
20 [GO] 2022―Apr―22 Changes in ganglioside antibody positivity rates during the COVID-19 pandemic Michael K. Racke, Justin K. Niles, Raymond A. Lorenz, Harvey W. Kaufman
21 [GO] 2022―Mrz―05 The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit Pablo Diaz, Marie Leveque, Geoffroy Hautecloque, François Sellal, Olivier Augereau, Livinia Lita, Estelle Biegle, Lounis Belilita, Charles Boutera, Pierre Rerat, Antonio Alvarez Gonzalez, Martin Martinot, Victor Gerber
22 [GO] 2021―Dez―13 Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab Ivan Adamec, Dunja Rogić, Monika-Gabriele Penz, Carola Braun, Mario Habek
23 [GO] 2021―Dez―09 New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure Karlo Toljan, Moein Amin, Amy Kunchok, Daniel Ontaneda
24 [GO] 2021―Dez―08 Stellate ganglion block reduces symptoms of long COVID: A case series Luke D. Liu, Deborah L. Duricka
25 [GO] 2021―Nov―18 Comments on “Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine” by , J Neuroimmunol Céline Caravagna
26 [GO] 2021―Nov―09 A systematic review of cases of CNS demyelination following COVID-19 vaccination Ismail Ibrahim Ismail, Sara Salama
27 [GO] 2021―Okt―21 Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine Juichi Fujimori, Kouichi Miyazawa, Ichiro Nakashima
28 [GO] 2021―Okt―06 Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection Mariana Dias da Costa, Miguel Leal Rato, Diana Cruz, Anabela Valadas, Ana Patrícia Antunes, Luísa Albuquerque
29 [GO] 2021―Sep―29 The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases Viviana Falcón Cama, Javier Marín-Prida, Nelson Acosta-Rivero, Emilio F. Acosta, Leonardo Oramas Díaz, Ana V. Casadesús, Briandy Fernández-Marrero, Nathalie Gilva-Rodríguez, Daina Cremata-García, Majel Cervantes-Llanos, Beatriz Piniella-Matamoros, Daisy Sánchez, Leticia del Rosario-Cruz, Israel Borrajero, Angelina Díaz, Yorexis González, Eduardo Pentón-Arias, Teresita Montero-González, Gerardo Guillen-Nieto, Giselle Pentón-Rol
30 [GO] 2021―Sep―17 AstraZeneca COVID-19 vaccine and Guillain-Barre’ Syndrome in Tasmania: A causal link? Wai M. Oo, Pradeep Giri, Aaron De Souza
31 [GO] 2021―Aug―28 Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report Zahra Pourmoghaddas, Atefeh Sadeghizadeh, Seyedeh Zahra Tara, Alireza Zandifar, Hamid Rahimi, Rana Saleh, Mohammadreza Ghazavi, Omid Yaghini, Neda Hosseini, Niloofar Javadi, Mohammad Saadatnia, Arastoo Vossough
32 [GO] 2021―Aug―28 SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy Josef Finsterer
33 [GO] 2021―Aug―16 Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study Mario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, Dunja Rogić, Barbara Barun, Tereza Gabelić, Andreja Emeršič, Alenka Horvat Ledinek, Nevena Grbić, Ivana Lapić, Dragan Šegulja, Koraljka Đurić, Ivan Adamec, Magdalena Krbot Skorić
34 [GO] 2021―Aug―08 COVID-19 in Cladribine-treated patient with multiple sclerosis Nitsan Haham, Adi Vaknin-Dembinsky
35 [GO] 2021―Aug―08 Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature Young Gi Min, Woohee Ju, Ye-Eun Ha, Jae-Jun Ban, Seolah Lee, Jung-Joon Sung, Je-Young Shin
36 [GO] 2021―Jul―31 Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association? Elisa Vegezzi, Sabrina Ravaglia, Gabriele Buongarzone, Paola Bini, Luca Diamanti, Matteo Gastaldi, Paolo Prunetti, Elisa Rognone, Enrico Marchioni
37 [GO] 2021―Jul―27 Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases Laura Zelada-Ríos, Kevin Pacheco-Barrios, Milagros Galecio-Castillo, Cesar Yamunaqué, Kelvin Álvarez, Ricardo Otiniano-Sifuentes
38 [GO] 2021―Jul―13 Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine Luca Baldelli, Giulia Amore, Angelica Montini, Ivan Panzera, Simone Rossi, Pietro Cortelli, Maria Guarino, Rita Rinaldi, Roberto D'Angelo
39 [GO] 2021―Jul―10 Commentary: The spectrum of neurological manifestations related to COVID-19 and vaccinations Rohini D. Samudralwar
40 [GO] 2021―Jul―10 Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms Anton Johansson, Mohamed S. Mohamed, Thiago C. Moulin, Helgi B. Schiöth
41 [GO] 2021―Jun―30 Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis Ritwik Ghosh, Souvik Dubey, Arpan Mandal, Biman Kanti Ray, Julian Benito-León
42 [GO] 2021―Jun―24 A case of longitudinally extensive transverse myelitis following vaccination against Covid-19 Claudia Pagenkopf, Martin Südmeyer
43 [GO] 2021―Jun―12 Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis Jibrin Danladi, Hemmen Sabir
44 [GO] 2021―Jun―07 Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement Saúl Reyes, Anthony L. Cunningham, Tomas Kalincik, Eva Kubala Havrdová, Noriko Isobe, Julia Pakpoor, Laura Airas, Reem F. Bunyan, Anneke van der Walt, Jiwon Oh, Joela Mathews, Farrah J. Mateen, Gavin Giovannoni
45 [GO] 2021―Jun―07 New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine Yasser Aladdin, Bader Shirah
46 [GO] 2021―Jun―05 Dimensions of SARS-CoV-2 associated Guillain-Barré syndrome J. Finsterer, R. Ghosh
47 [GO] 2021―Mai―29 Post-infectious rhombencephalitis after coronavirus-19 infection: A case report and literature review Valerie Jeanneret, Daniel Winkel, Aida Risman, Hang Shi, Grace Gombolay
48 [GO] 2021―Mai―13 Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies Josef Finsterer, Fulvio A. Scorza, Carla A. Scorza, Ana C. Fiorini
49 [GO] 2021―Mai―04 Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients Hannah Kelly, Brent Sokola, Hesham Abboud
50 [GO] 2021―Apr―28 Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up Nowshin Papri, Shoma Hayat, Asif Mohammed, Md. Nure Alam Afsar, Imran Hasan, Ananna Rahman, Israt Jahan, Zhahirul Islam
51 [GO] 2021―Apr―18 Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review Abu Baker Sheikh, Prabal Kumar Chourasia, Nismat Javed, Mehul Kumar Chourasia, Sajid S. Suriya, Shubhra Upadhyay, Fatima Ijaz, Suman Pal, Narges Moghimi, Rahul Shekhar
52 [GO] 2021―Apr―16 Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities Homa Pourriyahi, Amene Saghazadeh, Nima Rezaei
53 [GO] 2021―Apr―01 Steroid-responsive, transverse myelitis is a known complication of COVID-19 J. Finsterer
54 [GO] 2021―Feb―21 Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature Maria M. Escobar, Saurabh Kataria, Erum Khan, Roshan Subedi, Medha Tandon, Kirthika Peshwe, Joshua Kramer, Faraze Niaze, Shitiz Sriwastava
55 [GO] 2021―Feb―15 COVID-19, HHV6 and MOG antibody: A perfect storm Muruj Jumah, Farah Rahman, Mark Figgie, Ankita Prasad, Anthony Zampino, Ali Fadhil, Kaitlin Palmer, Robin Arthur Buerki, Steven Gunzler, Praveen Gundelly, Hesham Abboud
56 [GO] 2020―Nov―11 A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection Ritwik Ghosh, Kaustav De, Devlina Roy, Arpan Mandal, Subrata Biswas, Subhrajyoti Biswas, Swagatam Sengupta, Dinabandhu Naga, Mrinalkanti Ghosh, Julián Benito-León
57 [GO] 2020―Nov―07 COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report Reza Boostani, Fariborz Reazai Talab, Naser Tayyebi Meibodi, Fariba Zemorshidi
58 [GO] 2020―Nov―07 SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, Vahid Davoudi, Fatemeh Hajighasemi, Mehdi Ghasemi
59 [GO] 2020―Sep―25 Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM) Omar Hussein, Ahmed Abd Elazim, Michel T. Torbey
60 [GO] 2020―Sep―24 COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment Lorenzo Muccioli, Umberto Pensato, Ilaria Cani, Luca Guerra, Federica Provini, Giorgio Bordin, Luca Albini Riccioli, Raffaele Lodi, Paolo Tinuper, Francesca Bisulli
61 [GO] 2020―Jul―15 The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia Maria Rosa Ciardi, Maria Antonella Zingaropoli, Patrizia Pasculli, Valentina Perri, Matteo Tartaglia, Serena Valeri, Gianluca Russo, Antonella Conte, Claudio Maria Mastroianni
62 [GO] 2020―Jul―14 Hemorrhagic encephalopathy associated with COVID-19 Jonathan D. Krett, Gordon A.E. Jewett, Charissa Elton-Lacasse, Kevin Fonseca, Christopher Hahn, Selena Au, Marcus W. Koch
63 [GO] 2020―Jun―20 Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report Mohammad Amin Farzi, Hormoz Ayromlou, Naser Jahanbakhsh, Parisa Hadavi Bavil, Abdolali Janzadeh, Farid Karkon Shayan
64 [GO] 2020―Mai―31 Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration Michael K. Racke, Scott D. Newsome
65 [GO] 2020―Mai―29 Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection Marco Chiarini, Simone Paghera, Daniele Moratto, Nicola De Rossi, Mauro Giacomelli, Raffaele Badolato, Ruggero Capra, Luisa Imberti
66 [GO] 2020―Mrz―04 HLA associations in narcolepsy type 1 persist after the 2009 H1N1 pandemic Mink Schinkelshoek, Rolf Fronczek, Willem Verduijn, Geert Haasnoot, Sebastiaan Overeem, Claire Donjacour, Astrid van der Heide, Dave Roelen, Frans Claas, Gert Jan Lammers
 [1] 

66 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec